San Diego, CA -- (SBWIRE) -- 04/19/2016 -- An investigation was announced for investors of aTyr Pharma Inc (NASDAQ:LIFE) shares over potential securities laws violations by aTyr Pharma and certain of its directors and officers was announced.

Investors who purchased shares of aTyr Pharma Inc (NASDAQ:LIFE), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of aTyr Pharma Inc (NASDAQ:LIFE) concerning whether a series of statements by aTyr Pharma regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

aTyr Pharma Inc went public in May 2015 and shares of aTyr Pharma Inc (NASDAQ:LIFE) rose to as high as $27.88 per share in June 2015. Since then shares of aTyr Pharma Inc (NASDAQ:LIFE) have declined significantly. In fact, shares of aTyr Pharma Inc declined to as low as $3.03 per share on April 8, 2016.

On April 15, 2016, NASDAQ:LIFE shares closed at $4.19 per share.

Those who purchased shares of aTyr Pharma Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com